Dr. Amy Dawn Brockmeyer, MD

Dr. Brockmeyer practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Dr. Brockmeyer's NPI, 1891959862, was assigned on July 17, 2008. Dr. Brockmeyer graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2002. Dr. Brockmeyer holds Washington license MD60087847.

Dr. Brockmeyer's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

Dr. Brockmeyer's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Brockmeyer is also affiliated with Virginia Mason Medical Center. The medical group on file is Franciscan Orthopedics - Silverdale. Dmand AI also links Dr. Brockmeyer to 2 more hospitals, 2 group practices and clinics, 1 imaging center and 1 medical group, each named with a free account. Dr. Brockmeyer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brockmeyer practices, 7 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Brockmeyer's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Brockmeyer is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Brockmeyer's licenses on file in 4 states: Washington, California, Alaska and Arizona.

Dmand AI lists hysterectomy among the conditions Dr. Brockmeyer treats.

CMS data shows 453 Medicare services from Dr. Brockmeyer across 10 procedure codes in 2024, for 114 Medicare patients. Medicare paid $48,055 for them.

CMS counts 114 Medicare patients who saw Dr. Brockmeyer in 2024. The largest group is 65 to 74, with 58 patients. 63% of them have high cholesterol, and 57% have high blood pressure. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brockmeyer's median patient age at 70, with 100% women.

In 2024, Dr. Brockmeyer wrote 163 Medicare Part D claims for 49 patients. 95% of them were for generic drugs. CMS names the drug for 84 of them, across 5 drugs with 11 or more claims each, at $2,540 in total drug cost. In 2023, CMS named 61 claims across 3 drugs.

Dr. Brockmeyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brockmeyer as offering telehealth. CMS counts 19 procedures of removal of the uterus by Dr. Brockmeyer, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Brockmeyer, published from 2007 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms. Dr. Brockmeyer's most frequent co-authors are Michelle F. Benoit, MD, Uma Chandavarkar, MD and Louis Dubeau, MD.

Dmand AI links Dr. Brockmeyer to 6 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Adenocarcinoma, Clear Cell, Brenner Tumor and Neurotoxicity Syndromes. Gynecologic Oncology Group sponsors the most, 4.

CMS Open Payments shows 30 general payments to Dr. Brockmeyer from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,601.

Dmand AI lists 2 awards for Dr. Brockmeyer, most recently CMS Stage 1 EHR in 2013.

Dr. Brockmeyer graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2002. Dr. Brockmeyer is a member of American College of Obstetricians and Gynecologists.

Dr. Brockmeyer is in network with 16 carriers, including United Healthcare, Elevance and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.